Trajectories of lung function in patients with idiopathic pulmonary fibrosis (IPF)

Please find below a graphical abstract summarising data on trajectories of forced vital capacity (FVC) and diffusing capacity (DLco) in patients with IPF in the IPF-PRO Registry.

Neely ML et al. Lung function trajectories in patients with idiopathic pulmonary fibrosis. Respir Res 2023;24(1):209.

Header - Navigation Icon

The IPF-PRO/ILD-PRO Registry is supported by Boehringer Ingelheim Pharmaceuticals, Inc (BIPI) and run in collaboration with the Duke Clinical Research Institute (DCRI) and enrolling centers. The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE). The authors did not receive payment for development of this graphical abstract or the article on which it is based. Writing support was provided by Julie Fleming and Wendy Morris of Fleishman-Hillard, London, UK, which was contracted and funded by BIPI. Boehringer Ingelheim (BI) was given the opportunity to review the article and graphical abstract for medical and scientific accuracy as well as intellectual property considerations.